期刊名称：EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Eye & Contact Lens: Science and Clinical Practice is the official journal of the Contact Lens Association of Ophthalmologists (CLAO), an international educational association for refractive eyecare. This scientific, peer-reviewed medical journal is the only one of its kind to address all aspects of refractive science - contact lenses, optical dispensing, refractive surgery and related anterior segment disease.
Instructions to Authors
SCOPE
Eye & Contact Lens: Science and Clinical Practice is a peer-reviewed, scientific journal for the submission of original manuscripts describing clinical observations, clinical trials, basic investigation, and case reports related to diseases of and medical and surgical treatment of the cornea and ocular surface, especially related to contact lens wear.
Ethical/Legal Considerations
A submitted manuscript must be an original contribution not previously published (except as an abstract or a preliminary report), must not be under consideration for publication elsewhere, and, if accepted, must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher. All manuscripts must be submitted online through the journal’s Web site: http://www.editorialmanager.com/ecl/. See submission instructions under “Online manuscript submission.�BR>
Patient anonymity and informed consent: It is the author’s responsibility to ensure that a patient’s anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.
Copyright: All authors must sign a copy of the Journal’s “Authorship Responsibility, Financial Disclosure, and Copyright Transfer�form and submit it at the time of manuscript submission.
Compliance with NIH and Other Research Funding Agency Accessibility Requirements
A number of research funding agencies now require or request authors to submit the post-print (the article after peer review and acceptance but not the final published article) to a repository that is accessible online by all without charge. As a service to our authors, LWW will identify to the National Library of Medicine (NLM) articles that require deposit and will transmit the post-print of an article based on research funded in whole or in part by the National Institutes of Health, Wellcome Trust, Howard Hughes Medical Institute, or other funding agencies to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism.
Permissions: Authors must submit written permission from the copyright owner (usually the publisher) to use direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along with complete details about the source. Any permissions fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material, not the responsibility of Lippincott Williams & Wilkins.
Manuscript Submission
Online manuscript submission: All manuscripts must be submitted online through http://www.editorialmanager.com/ecl/ First-time users: Please click the Register button from the menu at the top of the page and enter the requested information. On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference. Note: If you have received an e-mail from us with an assigned user ID and password, or if you are a repeat user, do not register again. Just login using the login button in the upper-left hand corner of the screen. Once you have an assigned ID and password, you do not have to re-register, even if your status changes (that is, author, reviewer, or editor). Authors: Please click the log-in button from the menu at the top of the page and log in to the system as an Author. Submit your manuscript according to the author instructions. You will be able to track the progress of your manuscript through the system. If you experience any problems, please contact Anita Fonn at anita@scimail.uwaterloo.ca; fax: 519-884-8769; phone: 519-888-4567, ext. 38210. Requests for help and other questions will be addressed in the order received.
Preparation of Manuscript
Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Title page(must include the following):
(a) complete manuscript title
(b) authors�full names, highest academic degrees, and affiliations
(c) name and address for correspondence, including e-mail address, telephone number, and fax number
(d) disclosure of all sources of support, including pharmaceutical and industry support, that require acknowledgment or a statement indicating there is no support to disclose.
Please note: The title page must also include disclosure of funding received for this work from any of the following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes Medical Institute (HHMI); and other(s).
Structured abstract and key words: Limit the abstract to 250 words. Do not cite references in the abstract. Limit the use of abbreviations and acronyms. Use the following subheads: Objectives, Methods, Results, and Conclusions. List three to five key words.
Text: Organize the manuscript into four main headings: Introduction, Materials and Methods, Results, and Discussion. Define abbreviations at first mention in text and in each table and figure. If a brand name is cited, supply the manufacturer's name and location (city and state/country).
Abbreviations: For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of measure.
References: The authors are responsible for the accuracy of the references. Key the references (double-spaced) at the end of the manuscript. Cite the references in text in the order of appearance. Cite unpublished data—such as papers submitted but not yet accepted for publication and personal communications, including e-mail communications—in parentheses in the text. If there are more than three authors, name only the first three authors and then use et al. Refer to the List of Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:
Journal article
1. Rand NS, Dawson JM, Juliao SF, et al. In vivo macrophage recruitment by murine intervertebral disc cells. J Spinal Disord. 2001;14:339--342.
Book chapter
2. Todd VR. Visual information analysis: frame of reference for visual perception. In: Kramer P, Hinojosa J, eds. Frames of Reference for Pediatric Occupational Therapy. Philadelphia, PA: Lippincott Williams & Wilkins; 1999:205�56.
Entire book
3. Kellman RM, Marentette LJ. Atlas of Craniomaxillofacial Fixation. Philadelphia, PA: Lippincott Williams & Wilkins; 1999.
Software
4. Epi Info [computer program]. Version 6. Atlanta, GA: Centers for Disease Control and Prevention; 1994.
Online journals
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol [serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, McLean, VA. Accessed December 15, 1990.
Database
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. Updated March 29, 1996.
World Wide Web
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS Web site]. June 1, 1996. Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.
Figures: Art should be created/scanned and saved and submitted as either a TIFF (tagged image file format), an EPS (encapsulated PostScript) file, or a PPT (PowerPoint) file. Line art must have a resolution of at least 1200 dpi (dots per inch). Electronic photographs, radiographs, CT scans, scanned images and so on must have a resolution of at least 300 dpi. If fonts are used in the artwork, they must be converted to paths or outlines or they must be embedded in the files. Color images must be created/scanned and saved and submitted as CMYK files. Please note that artwork generated from office suite programs such as CorelDRAW and MS Word and artwork downloaded from the Internet (JPEG or GIF files) cannot be used. Cite figures consecutively, and number them in the order in which they are discussed. All electronic art that cannot be successfully uploaded must be submitted on a 3½-inch high-density disk, a CD-ROM, or an Iomega Zip disk, accompanied by high-resolution laser prints of each image.
Figure legends: Include legends for all figures. They should be brief and specific, and they should appear on a separate manuscript page after the references. Use scale markers in the image for electron micrographs, and indicate the type of stain used.
Color figures: The journal accepts for publication color figures that will enhance an article. Authors who submit color figures will receive an estimate of the cost for color reproduction. If they decide not to pay for color reproduction, they can request that the figures be converted to black and white at no charge.
Tables: Create tables using the table creating and editing feature of your word processing software (eg, Word, WordPerfect). Do not use Excel or comparable spreadsheet programs. Group all tables in a separate file. Cite tables consecutively in the text, and number them in that order. Each table should appear on a separate sheet and should include the table title, appropriate column heads, and explanatory legends (including definitions of any abbreviations used). Do not embed tables within the body of the manuscript. They should be self-explanatory and should supplement, rather than duplicate, the material in the text.
Style: Pattern manuscript style after the American Medical Association Manual of Style (9th edition). Stedman’s Medical Dictionary (27th edition) and Merriam Webster’s Collegiate Dictionary (10th edition) should be used as standard references. Refer to drugs and therapeutic agents by their accepted generic or chemical names, and do not abbreviate them. The name should not be abbreviated. Use code numbers only when a generic name is not yet available. In that case, supply the chemical name and a figure giving the chemical structure of the drug is required. Copyright or trade names of drugs should be capitalized and placed in parentheses after the name of the drug. Names and locations (city and state in USA; city and country outside USA) of manufacturers of drugs, supplies, or equipment cited in a manuscript are required to comply with trademark law and should be provided in parentheses. Units of measure should be expressed in the metric system, and temperatures should be expressed in degrees Celsius. Conventional units should be written as SI units as appropriate.
Supplemental Digital Content: Authors may submit supplemental digital content to enhance their article’s text and to be considered for online-only posting. Supplemental digital content may include the following types of content: text documents, graphs, tables, figures, graphics, illustrations, audio, and video. Cite all supplemental digital content consecutively in the text. Citations should include the type of material submitted, should be clearly labeled as “Supplemental Digital Content,�should include a sequential number, and should provide a brief description of the supplemental content. Provide a legend of supplemental digital content at the end of the text. List each legend in the order in which the material is cited in the text. The legends must be numbered to match the citations from the text. Include a title and a brief summary of the content. For audio and video files, also include the author name, videographer, participants, length (minutes), and size (MB). Authors should mask patients' eyes and remove patients' names from supplemental digital content unless they obtain written consent from the patients and submit written consent with the manuscript. Copyright and Permission forms for article content including supplemental digital content must be completed at the time of submission.
Supplemental Digital Content Size & File Type Requirements: To ensure a quality experience for those viewing supplemental digital content, it is suggested that authors submit supplemental digital files no larger than 10 MB each. Documents, graphs, and tables may be presented in any format. Figures, graphics, and illustrations should be submitted with the following file extensions: .tif, .eps, .ppt, .jpg, .pdf, .gif. Audio files should be submitted with the following file extensions: .mp3, .wma. Video files should be submitted with the following file extensions: .wmv, .mov, .qt, .mpg, .mpeg, .mp4. Video files should also be formatted with a 320 X 240 pixel minimum screen size. For more information, please review LWW’s requirements for submitting supplemental digital content: http://links.lww.com/A142
After Acceptance
Page proofs and corrections: Corresponding authors will receive electronic page proofs to check the copyedited and typeset article before publication. Portable document format (PDF) files of the typeset pages and support documents (eg, reprint order form) will be sent to the corresponding author by e-mail. Complete instructions will be provided with the e-mail for downloading and printing the files and for sending the corrected page proofs to the publisher. Those authors without an e-mail address will receive traditional page proofs. It is the author’s responsibility to ensure that there are no errors in the proofs. Changes that have been made to conform to journal style will stand if they do not alter the authors' meaning. Only the most critical changes to the accuracy of the content will be made. Changes that are stylistic or are a reworking of previously accepted material will be disallowed. The publisher reserves the right to deny any changes that do not affect the accuracy of the content. Authors may be charged for alterations to the proofs beyond those required to correct errors or to answer queries. Proofs must be checked carefully and corrections submitted within 24 to 48 hours of receipt, as requested in the cover letter accompanying the page proofs.
Reprints: Authors will receive a reprint order form and a price list with the page proofs. Reprint requests should be faxed with the corrected proofs, if possible. Reprints are normally shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint Department, Lippincott Williams & Wilkins, 351 W. Camden Street, Baltimore, MD 21201; Fax: 410.528.4434; E-mail: reprints@wolterskluwer.com with any questions.
Publisher's contact: Fax corrected page proofs, reprint order form, color letters, and any other related materials to Journal Production Editor, Eye & Contact Lens: Science and Clinical Practice, Lippincott Williams & Wilkins, 351 W. Camden Street, Baltimore, MD 21201; phone: 410-528-4102; fax: 443-451-8147.
Editorial Board
| Editor-in-Chief |
Desmond Fonn, DipOptom, MOptom, FAAO
Waterloo, ON, Canada |
Associate Editor-in-Chief |
Oliver Schein, MD, MPH, MBA
Baltimore, MD |
Managing Editor
Anita Fonn |
Editor Emeritus
H. Dwight Cavanagh, MD, PhD
Dallas, TX |
Editorial Board |
Penny Asbell
New York, NY
Joseph T. Barr
Rochester, NY
William J. Benjamin
Birmingham, AL
Jan Bergmanson
Houston, TX
Joseph Bonanno
Bloomington, IN
Leo G. Carney
Kelvin Grove, Queensland, Australia
H. Dwight Cavanagh
Dallas, TX
Peter C. Donshik
Bloomfield, CT
Donald J. Doughman
Minneapolis, MN
Michael Doughty
Glasgow, Scotland
William T. Driebe
Gainesville, FL
Nathan Efron
Brisbane, Queensland, Australia
Paul M. Erickson
Rochester, NY
Suzanne Fleiszig
Berkeley, CA
Gary Foulks
Louisville, KY
William Gleason
Wilmington, MA
Michel Guillon
London, England
Brien A. Holden
Sydney NSW, Australia
James V. Jester
Irvine, CA
Atsushi Kanai
Tokyo, Japan
Shigeru Kinoshita
Kyoto, Japan
Donald Korb
Boston, MA
Carol Lakkis
Carlton, Victoria, Australia
Robert M. Lavker
Chicago, IL
|
James P. McCulley
Dallas, TX
Timothy McMahon
Chicago, IL
John J. McNally
Duluth, GA
Jason J. Nichols
Columbus, OH
Teruo Nishida
Ube City Yamaguchi, Japan
W. Matthew Petroll, PhD
Dallas, TX
Stephen C. Pflugfelder
Houston, TX
Kenneth Polse
Berkeley, CA
Danielle Robertson
Dallas, TX
Robert A. Sack
New York, NY
Fiona J. Stapleton
Sydney, NSW, Australia
Thomas L. Steinemann
Cleveland, OH
Ralph Stone
Fort Worth, TX
David A. Sullivan
Boston, MA
Helen A. Swarbick
Sydney, NSW, Australia
Deborah F. Sweeney
Sydney, NSW, Australia
Alan Tomlinson
Glasgow, Scotland
James Walsh
Dublin, Ireland
Richard Weisbarth
Atlanta, GA
Barry Weissman
Los Angeles, CA
Mark D. Wilcox
Sydney NSW, Australia
Graeme Wilson
Bloomington, IN
Craig Woods
Waterloo, ON, Canada
|
Eye & Contact Lens: Science and Clinical Practice |
| H. Dwight Cavanagh, MD, PhD |
2003-2007 |
The CLAO Journal |
| H. Dwight Cavanagh, MD, PhD |
2003 - 2003 |
| Peter C. Donshik, MD |
1993 - 2002 |
| Elizabeth J. Cohen, MD |
1988 - 1992 |
| R. Linsy Farris, MD |
1983 - 1987 |
The Contact Lens and Intraocular Lens Journal (became The CLAO Journal) |
| Jack Hartstein, MD |
1975 - 1982 |
|
